Chongqing Tianru Biotechnology Co., Ltd.

Chongqing Tianru Biotechnology Co., Ltd. is a high-tech enterprise integrating R&D, production, and sales. It is located on the 4th floor, Building 5, Liangjing Industrial Park, No. 37 Cuitao Road, Cuiyun, Liangjiang New Area. The company mainly focuses on the digestive field, especially the development, promotion, and sales of innovative medical device products in the field of early diagnosis and treatment of gastrointestinal cancer. The company has a medical device production workshop including a purification workshop of more than 500 square meters, has passed the aseptic medical device production system audit, and possesses production, inspection, and R&D instruments and equipment suitable for registered products and products under development. The company's developed product, the Gastrointestinal Endoscopy Visual Field Clarity Enhancer (ESCGV), has completely independent intellectual property rights and has been rated as a key pharmaceutical product and key new product of Chongqing. The product project has received support from multiple sources, including the Ministry of Science and Technology and Chongqing's innovative medical device demonstration application promotion, the Chongqing Science and Technology Commission's livelihood projects and new technology projects. Based on ESCGV and its dedicated consumable flushing kit, a digestive endoscopy flushing technique has been established, and its newly added medical service price items have been approved by the Chongqing Medical Security Bureau, the Hubei Provincial Medical Security Bureau, and the Guangxi Zhuang Autonomous Region Medical Security Bureau, respectively, while other provinces and cities are in the process of application or approval. The company's main product under development, the gastrointestinal endoscopy artificial intelligence-assisted examination and diagnosis system (Tianru No. 1), has received support from the 2019 Chongqing Key Science and Technology Project, won third prizes in two semifinals (Huawei Special Session and Tencent Special Session) of the 8th China Innovation and Entrepreneurship Competition in 2019, and won the second prize in the finals of the photoelectric and artificial intelligence category of the 3rd China Medical Device Innovation and Entrepreneurship Competition in 2020. The company attaches importance to the creation and protection of intellectual property, and has cumulatively applied for nearly 60 domestic and foreign patents and 23 trademarks, including 8 Chinese invention patents, 21 Chinese utility model patents, 6 Chinese design patents, 1 Japanese invention patent, 1 U.S. invention patent, and 1 EU invention patent have been authorized, and 20 trademarks have been registered.